Fresh Insights
September 3, 2019
Leveraging Digital Technology, Telemedicine, and Analytics to Transform Clinical Research
Digitalization of clinical trials will soon become the norm for pharma industry. In the industry’s ongoing quest to bring new...
Read More
July 31, 2019
Telemedicine: A promise of better outcomes or just connected care?
Up to 60% of the global population will suffer from chronic diseases such as heart failure, stroke, diabetes, blood pressure...
Read More
July 24, 2019
Innovations in Pharma Manufacturing: Current Trends and Future Outlook
Shifting demands, price and portfolio pressures are pushing pharma manufacturers to fast-track innovation Precision medicine is having a direct impact on...
Read More
April 22, 2019
To Deal Or Not To Deal: Lessons Learnt
The role of partnership in the pharmaceutical industry is ever increasing in realising the business goals. Our presentation provides a...
Read More
March 6, 2019
Rare Disease Situation Analysis
Rare Disease Situation Analysis is aimed at providing a high level glimpse into the rare disease drug development and commercialization. Rare disease drug development has been an increasingly attractive proposition for biopharmaceutical companies.
Read More
May 25, 2018
Nanotechnology in Drug Discovery and Design
This presentation takes the reader on an exciting journey, about the Science beneath the development of Oncology Nano Drug delivery systems. How the tumor mico and macro environments throws conspicuous challenges to the nanotech field? Furthermore, the presentation also gives a sneak view of Nanotherapeutics clinical landscape across development strategies and tumors.
Read More
May 14, 2018
Biosimilar Clinical Development – A Strategic Lever?
The presentation gives some key insights on the emerging biosimilars developer landscape with focus on US, EU, China, Japan, South Korea, MENA and Indian markets. Furthermore, it provides a detailed analysis on Clinical differentiation of players for major products (Bevacizumab, Trastuzumab, Adalimumab, Rituximab, Infliximab and etanercept).
Read More
February 12, 2018
Key Considerations When Developing a DOAC – Part 3
The currently approved direct oral anti-coagulants have proven to be safe and efficacious in prevention of stroke in patients with AF. However, the choice of DOAC is influenced by several factors including specific patient characteristics (renal function etc.), preference of OD versus BID, physicians comfort with the drug and the cost of drug to the patient.
Read More
December 21, 2017
Entrepreneurship Opportunities for Millennials in Pharma
Indian start-up ecosystem has been steadily growing with over 5200 start-ups in the country today. India has become the world’s...
Read More
August 10, 2017
The Wearable Story – Part 1
The rapid consumer adoption of wearable devices for the collection of health data has inspired the next revolution in clinical trial operations. The integration of wearable health monitors with smartphones has opened up several fronts in clinical research. These integrated device-app-database systems can increase the frequency and accuracy of data collection, improve operational efficiencies, and achieve greater patient engagement in the clinical trial process.
Read More